Neurocrine Biosciences
NBIX
#1574
Rank
A$20.24 B
Marketcap
A$203.03
Share price
0.16%
Change (1 day)
-11.31%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company